| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
ID: ALA5180658
Max Phase: Preclinical
Molecular Formula: C26H23N3O2
Molecular Weight: 409.49
Associated Items:
Representations
Canonical SMILES: O=Cc1cccc([C@@H]([C@H](Nc2ccccn2)c2ccccc2)[C@@H](O)c2ccccc2)n1
Standard InChI: InChI=1S/C26H23N3O2/c30-18-21-14-9-15-22(28-21)24(26(31)20-12-5-2-6-13-20)25(19-10-3-1-4-11-19)29-23-16-7-8-17-27-23/h1-18,24-26,31H,(H,27,29)/t24-,25+,26-/m0/s1
Standard InChI Key: BIVVDLOPGBAPFO-NXCFDTQHSA-N
Associated Targets(Human)
Bile acid transporter 197 Activities
Associated Targets(non-human)
Hepatitis delta virus 13 Activities
| Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
|---|
Molecule Features
| Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
| Molecule Type: | Topical: No | First In Class: No | Black Box: No |
| Chirality: No | Availability: No | Prodrug: No |
Drug Indications
| MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
|---|
Mechanisms of Action
| Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
|---|
Properties
| Molecular Weight: 409.49 | Molecular Weight (Monoisotopic): 409.1790 | AlogP: 4.96 | #Rotatable Bonds: 8 |
| Polar Surface Area: 75.11 | Molecular Species: NEUTRAL | HBA: 5 | HBD: 2 |
| #RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
| CX Acidic pKa: 13.91 | CX Basic pKa: 6.55 | CX LogP: 4.87 | CX LogD: 4.81 |
| Aromatic Rings: 4 | Heavy Atoms: 31 | QED Weighted: 0.40 | Np Likeness Score: -0.61 |
References
| 1. Chen S, Zhang L, Chen Y, Fu L.. (2022) Inhibiting Sodium Taurocholate Cotransporting Polypeptide in HBV-Related Diseases: From Biological Function to Therapeutic Potential., 65 (19.0): [PMID:36111355] [10.1021/acs.jmedchem.2c01097] |
Source
Source(1):